Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Puerto Rico for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Puerto Rico only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Puerto Rico (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Alivia Infusion Services LLC (NPI 1881915031)

Field	Value
Entity Type	Organization
Organization	Alivia Infusion Services LLC
Address	107 El Tuque Industrial Park
City	Ponce
State	PR
ZIP	00728
Taxonomy	Home Infusion Therapy Pharmacy
NPI Enumerated	June 22, 2010

Payer Source	Total Paid
Medicaid	$10.9M
Medicare	$0

Key Findings

ALIVIA INFUSION SERVICES LLC is effectively a single-payer Medicaid operator: there is no Medicare billing on file and the provider reports $10.9M in lifetime Medicaid revenue, indicating that its entire reported government revenue base in our dataset is Medicaid-driven. This payer concentration suggests operational dependence on Medicaid policies and reimbursement for home infusion services.

Revenue concentration is high: the precomputed top three Medicaid codes account for 74.7% of this provider's total Medicaid revenue, which signals that a small set of service lines (initial IV infusion, pharmacy compounding/dispensing, and home infusion per-diem services) drive most of reported income. That concentration could create sensitivity to changes in reimbursement or utilization for those specific codes.

The single largest revenue driver is 96365 (initial intravenous infusion up to one hour), which generated $4.5M and represents 41.3% of the provider's Medicaid revenue. ALIVIA ranks #5 of 63 providers in-state for 96365 (94th percentile) and the activity is labeled as "typical, unremarkable volume," indicating the organization is a meaningful but not anomalous participant in delivering initial IV infusions across the state.

Two administration/coordination codes together account for a large share of revenue: S9430 (pharmacy compounding and dispensing services) and S9494 (home infusion therapy per diem) each contributed $1.8M, or 16.7% of Medicaid revenue apiece. S9430 is reported only by this provider in-state (rank #1 of 1, with no state peer comparison available), which may reflect a unique billing practice or a specialized compounding/dispensing footprint; S9494 ranks #4 of 9 providers in-state (63th percentile) and is labeled "typical, unremarkable volume," consistent with a routine home infusion administrative role.

The code mix is strongly consistent with an outpatient parenteral antimicrobial therapy (OPAT) and home infusion pharmacy model: high-volume use of initial infusion coding (96365) plus per-diem home infusion (S9494) and compounding/dispensing (S9430) combined with multiple high-cost antibiotic J-codes (for example, J0878 daptomycin $1.1M, J1335 ertapenem $897.8K) indicates the provider delivers and manages IV antibiotic therapies and associated pharmacy services in the home setting. This combination implies responsibilities for drug procurement/compounding, care coordination, and nursing administration.

Several single-agent antibiotic J-codes appear among secondary revenue drivers and show the provider is a leading in-state supplier for specific drugs: J0878 (daptomycin) produced $1.1M and ranks #1 of 2 providers in-state (100th percentile, labeled "typical, unremarkable volume"); J1335 (ertapenem) produced $897.8K and ranks #3 of 4 (33th percentile). These rank positions indicate ALIVIA is a primary in-state supplier for certain high-cost agents while competing modestly for others.

Competitive standing is mixed by measure: for broad infusion activity (96365) ALIVIA is in the upper decile statewide (94th percentile) among a large cohort (63 providers), showing strong placement in initial IV infusion volume; for some specialized codes it is either the sole reporter in-state (S9430) or a top reporter among very few peers (multiple J-codes rank #1 of small N), which suggests strength in niche dispensing/antibiotic supplies but not necessarily large-scale dominance across all home infusion services.

The provider has an established tenure in the dataset—its NPI was enumerated on 2010-06-22 (~16 years ago)—which supports that the observed billing profile reflects a multi-year operational presence rather than a recent entrant. Given the long tenure plus concentrated Medicaid revenue and code mix centered on IV antibiotics and home infusion coordination, analysts should view ALIVIA as a specialized, Medicaid-focused home infusion pharmacy with exposure to a few high-revenue codes and potential sensitivity to reimbursement or utilization shifts for those services.

Medicaid: Complete Services Breakdown

Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.

10 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	5,540	$820	$4.5M
S9430	Pharmacy compounding and dispensing services	2,380	$770	$1.8M
S9494	Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and…	1,900	$960	$1.8M
J0878	Injection, daptomycin, 1 mg	750	$1,430	$1.1M
J1335	Injection, ertapenem sodium, 500 mg	1,450	$620	$897.8K
J2185	Injection, meropenem, 100 mg	550	$570	$310.2K
J0696	Injection, ceftriaxone sodium, per 250 mg	840	$190	$156.1K
J0692	Injection, cefepime hydrochloride, 500 mg	990	$160	$153.8K
J3370	Injection, vancomycin hcl, 500 mg	660	$210	$135.8K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	110	$320	$35.6K

Medicaid: Competitive Analysis & Benchmarks

How this provider's Medicaid billing volume and revenue compare to other Puerto Rico providers billing the same CPT/HCPCS codes.

Claims Volume vs. Puerto Rico Distribution

Alivia Infusion Services LLC — 5 of 10 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Puerto Rico

Full comparison — all codes billed, vs. Puerto Rico median

10 rows

CPT/HCPCS Code	Description	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
S9430	Pharmacy compounding and dispensing services	1	10	2,380	$770	$1.8M
J0878	Injection, daptomycin, 1 mg	1	10	660	$1,050	$691.7K
J1335	Injection, ertapenem sodium, 500 mg	3	10	1,550	$350	$479.8K
S9494	Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and…	4	10	1,710	$100	$394.7K
J2185	Injection, meropenem, 100 mg	1	10	310	$530	$161.7K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	5	60	240	$100	$147.6K
J0692	Injection, cefepime hydrochloride, 500 mg	1	10	600	$140	$85.8K
J3370	Injection, vancomycin hcl, 500 mg	1	10	510	$120	$53.2K
J0696	Injection, ceftriaxone sodium, per 250 mg	4	20	60	$30	$25.6K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	1	10	90	$250	$22.2K

Nearby Providers

Other providers in the same ZIP code as Alivia Infusion Services LLC, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Lubilu Therapy Group, LLC	PR	Speech-Language Pathologist	$0	$9.2M
Laboratorio La Providencia De Ponce	PR	Clinical Medical Laboratory	$16.4K	$1.7M
Sheila Colon Villarrubia	PR	Public Health & General Preventive Medicine Physician	$0	$1.2M
S & R Laboratorio Clinico Corp	PR	Clinical Medical Laboratory	$1.7K	$846.2K
Miguel Echevarria Rodriguez	PR	Diagnostic Radiology Physician	$0	$820.6K
Sergio Collazo Sr	PR	Land Ambulance	$12.8K	$753.9K
Laboratorio Clinico El Tuque, Inc	PR	Clinical Medical Laboratory	$1.4K	$696.7K
Jesus Rodriguez Rodriguez	PR	General Practice Physician	$6.6K	$224.2K
Walgreen Co	PR	Pharmacy	$60.7K	$0
Luis Rodriguez Hernandez	PR	Internal Medicine Physician	$14.9K	$8.3K

Alivia Infusion Services LLC — Billing Profile & Reimbursement Data

Sign up for Alivia Infusion Services LLC — Billing Profile & Reimbursement Data policy alerts

Alivia Infusion Services LLC — Billing Profile & Reimbursement Data

Sign up for Alivia Infusion Services LLC — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicaid: Total Revenue Breakdown by CPT/HCPCS Code

Medicaid: Complete Services Breakdown

Medicaid: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References